CD39+ Tregs represent a potently suppressive Treg population with increased stability under inflammatory conditions.16 28–31 The majority of CD39+ CD4+ T cells in the TME of NSCLC are confined to the tumor stroma and a high frequency of CD39+CD4+ T cells predicts poor outcome. This evidence concerns the gene ENTPD1 and non-small cell lung carcinoma.